ConcertAI is a leading brand that offers powerful, integrated real-world data and AI-driven solutions. Their mission is to transform how insights are generated and accelerate therapeutic innovations for patients. As the new home for Concerto HealthAI, they are recognized as the clinical AI and RWD leader in the industry.

ConcertAI provides a wide range of products and services to meet the needs of healthcare professionals and researchers. Their real-world data products offer valuable insights for clinical trial optimization, predictive patient outcomes, and commercial solutions. They also offer TeraRecon digital trial solutions, which utilize advanced imaging technologies in healthcare.

With a dedicated team of scientists and data experts, ConcertAI collaborates with biopharma companies to drive improved patient outcomes and enhance clinical development. They offer innovative solutions for a variety of diseases, including AML, breast cancer, lung cancer, and many others. In addition to their products and services, ConcertAI provides resources such as research publications, news, blogs, webinars, and events.

They have established partnerships with reputable organizations like Caris Life Sciences, PathAI, and Janssen Pharmaceuticals to further advance healthcare research. ConcertAI is dedicated to making a positive impact in the healthcare industry by harnessing the power of AI and real-world data. Their commitment to innovation and collaboration has positioned them as a trusted partner for biopharma companies and healthcare professionals